Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 31 Oct 2024

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

in Hematologic Malignancies

Pierre Sesques
Lionel Karlin
Emmanuel Massy
Alizée Maarek
Guillaume Aussedat
Anne Lazareth
Camille Golfier
Fadhela Bouafia-Sauvy
Helene Lequeu
Dana Ghergus

Frontiers in Oncology

doi 10.3389/fonc.2024.1436587

2,188 views
1 citation

Case Report

Published on 31 Oct 2024

TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case report

in Hematologic Malignancies

Chang Chen
Jinman Zhong
Wanzhen Hu
Jiewen Tan

Frontiers in Oncology

doi 10.3389/fonc.2024.1484256

1,699 views
1 citation

Review

Published on 31 Oct 2024

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era

in Hematologic Malignancies

Evgenia Verigou
Theodora Chatzilygeroudi
Vasileios Lazaris
Anne-Lise de Lastic
Argiris Symeonidis

Frontiers in Oncology

doi 10.3389/fonc.2024.1447001

5,592 views
3 citations

Original Research

Published on 31 Oct 2024

The identification and correction of pseudohypercalcemia

in Hematologic Malignancies

Tongyong Yu
Xiaozhe Li
Beihui Huang
Jingli Gu
Junru Liu
Meilan Chen
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1441851

3,324 views
1 citation

Brief Research Report

Published on 24 Oct 2024

Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon

in Hematologic Malignancies

Souraya Rammal
Farid Abou Abdallah
Charbel Attieh
Zeinab El Mounajjed
Warde Semaan
Alain Chebly

Frontiers in Oncology

doi 10.3389/fonc.2024.1480793

1,884 views
2 citations

Review

Published on 22 Oct 2024

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Naseem Esteghamat
Aaron Tsumura
Gabriel Marquez-Arreguin
Joseph Tuscano

Frontiers in Oncology

doi 10.3389/fonc.2024.1481950

3,509 views
1 citation

Mini Review

Published on 22 Oct 2024

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma

in Hematologic Malignancies

Amanda F. Cashen

Frontiers in Oncology

doi 10.3389/fonc.2024.1392653

3,317 views
2 citations

Original Research

Published on 17 Oct 2024

Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study

in Hematologic Malignancies

Linda Preyer
Eik Vettorazzi
Walter Fiedler
Holger Rohde
Jannik Stemler
Saskia Gönner
Carsten Bokemeyer
Cyrus Khandanpour
Friederike Wortmann

Frontiers in Oncology

doi 10.3389/fonc.2024.1429221

2,583 views

Original Research

Published on 17 Oct 2024

COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)

in Hematologic Malignancies

Barath Prashanth Sivasubramanian
Shashvat Joshi
Diviya Bharathi Ravikumar
Madhumithaa Jagannathan
Sonia Babu
Shanthi Reddy Sripathi
Avinash Javvaji
Priyanshu Jain
Dinesh Kumar Shanmugam
Bharath Duraisamy Swami Kannan

Frontiers in Oncology

doi 10.3389/fonc.2024.1446482

3,406 views
2 citations

Editorial

Published on 17 Oct 2024

Editorial: Novelties in acute myeloid leukemia: from biology to clinical applications

in Hematologic Malignancies

Luca Vincenzo Cappelli
Nico Gagelmann
Hassan Awada
Carmelo Gurnari

Frontiers in Oncology

doi 10.3389/fonc.2024.1499272

1,407 views

Methods

Published on 14 Oct 2024

AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients

in Hematologic Malignancies

Susanne Jung
Annika Nelde
Yacine Maringer
Monika Denk
Lisa Zieschang
Christine Kammer
Melek Özbek
Peter Martus
Christopher Hackenbruch
Alexander Englisch

Frontiers in Oncology

doi 10.3389/fonc.2024.1458449

4,951 views
5 citations

Systematic Review

Published on 11 Oct 2024

Association of CTLA-4 polymorphisms with hematologic malignancy susceptibility: a meta-analysis

in Hematologic Malignancies

Xuefen Yan
Nana Zhang
Gang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1467740

1,683 views

Brief Research Report

Published on 09 Oct 2024

Survival outcomes of patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation in Germany: real-world evidence from an administrative database between 2010 and 2019

in Hematologic Malignancies

Jan-Michel Heger
Peter Borchmann
Sybille Riou
Barbara Werner
Michael S. Papadimitrious
Jörg Mahlich

Frontiers in Oncology

doi 10.3389/fonc.2024.1432310

2,430 views
1 citation

Correction

Published on 09 Oct 2024

Corrigendum: Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia

in Hematologic Malignancies

Meidan Hou
Yanan Huang
Jinsong Yan
Guoguang Fan

Frontiers in Oncology

doi 10.3389/fonc.2024.1472773

1,034 views

Original Research

Published on 02 Oct 2024

Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa

in Hematologic Malignancies

Anna Jonasova
Slavka Sotakova
Petra Belohlavkova
Lubomir Minarik
Tomas Stopka
Jan Jakub Jonas
Tatiana Aghova
Zuzana Zemanova

Frontiers in Oncology

doi 10.3389/fonc.2024.1398331

3,728 views
5 citations

Original Research

Published on 01 Oct 2024

The impact of delayed versus early administration of granulocyte colony-stimulating factor following autologous hematopoietic stem cell transplantation on transplantation outcome

in Hematologic Malignancies

Mahshid Mahdizadeh
Mohammad Amin Karimi
Zohreh Tajabadi
Vahid Kaveh
Shayan Zamani

Frontiers in Oncology

doi 10.3389/fonc.2024.1468948

2,162 views
1 citation

Case Report

Published on 26 Sep 2024

Platelet HLA gene bank digital matching technology for platelet transfusion refractory patients with malignant tumors: a case report

in Hematologic Malignancies

Xiang Gao
Jianhua Li
Xiuwen Ni
Lijun Wang
Peilin Hu
Xiaowei Zhu

Frontiers in Oncology

doi 10.3389/fonc.2024.1419485

1,422 views

Brief Research Report

Published on 24 Sep 2024

Acute myeloid leukemia cells adhere to bone marrow and acquire chemoresistance by downregulating UNC5B expression

in Hematologic Malignancies

Teng Teng
Liping Ren
Jilong Xiao
Zhiyu Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1394443

2,391 views
1 citation

Original Research

Published on 23 Sep 2024

Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response

in Hematologic Malignancies

Mónica del Rey González
Sohini Chakraborty
Jesús María Hernández-Sánchez
María Diez Campelo
Christopher Y. Park
Jesús María Hernández Rivas

Frontiers in Oncology

doi 10.3389/fonc.2024.1438052

3,063 views

Original Research

Published on 23 Sep 2024

How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective

in Hematologic Malignancies

Ann-Cathrine Siefen
Melina Sophie Kurte
Florian Jakobs
Marcel Teichert
Bastian von Tresckow
Hans Christian Reinhardt
Udo Holtick
Johannes Atta
Christian Jehn
Elisa Sala

Frontiers in Oncology

doi 10.3389/fonc.2024.1466803

3,059 views
4 citations

Review

Published on 23 Sep 2024

Ferroptosis: a new mechanism of traditional Chinese medicine for treating hematologic malignancies

in Hematologic Malignancies

Xinyue Gou
Xudong Tang
Chi Liu
Zhuo Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1469178

2,947 views
3 citations

Original Research

Published on 19 Sep 2024

Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis

in Hematologic Malignancies

Giuseppe Sapienza
Marta Castronovo
Stefania Tringali
Roberto Bono
Cristina Rotolo
Antonino Mulè
Valeria Calafiore
Caterina Patti
Cecilia Agueli
Valentina Randazzo

Frontiers in Oncology

doi 10.3389/fonc.2024.1441254

2,279 views
2 citations

Case Report

Published on 16 Sep 2024

Case report: Combination therapy with selinexor, decitabine and half-dose CAG regimen for relapsed elderly acute myeloid leukemia

in Hematologic Malignancies

Xueya Zhang
Yuqi Sun
Jinfa Zhong

Frontiers in Oncology

doi 10.3389/fonc.2024.1391329

1,817 views
1 citation

Review

Published on 13 Sep 2024

How we diagnose Myelodysplastic syndromes

in Hematologic Malignancies

Howard S. Oster
Moshe Mittelman

Frontiers in Oncology

doi 10.3389/fonc.2024.1415101

7,198 views
2 citations

2,007 articles

articles

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case report

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era

The identification and correction of pseudohypercalcemia

Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma

Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study

COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)

Editorial: Novelties in acute myeloid leukemia: from biology to clinical applications

AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients

Association of CTLA-4 polymorphisms with hematologic malignancy susceptibility: a meta-analysis

Survival outcomes of patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation in Germany: real-world evidence from an administrative database between 2010 and 2019

Corrigendum: Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia

Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa

The impact of delayed versus early administration of granulocyte colony-stimulating factor following autologous hematopoietic stem cell transplantation on transplantation outcome

Platelet HLA gene bank digital matching technology for platelet transfusion refractory patients with malignant tumors: a case report

Acute myeloid leukemia cells adhere to bone marrow and acquire chemoresistance by downregulating UNC5B expression

Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response

How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective

Ferroptosis: a new mechanism of traditional Chinese medicine for treating hematologic malignancies

Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis

Case report: Combination therapy with selinexor, decitabine and half-dose CAG regimen for relapsed elderly acute myeloid leukemia

How we diagnose Myelodysplastic syndromes